TRB Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.38M Sell
2,820
-1,585
-36% -$1.62M 0.45% 39
2026
Q1
$4.05M Buy
+4,405
New +$4.47M 0.58% 33

Other funds holding LLY

TRB Wealth Management's LLY Position: Q2 2026 in Review

TRB Wealth Management reduced its Eli Lilly (LLY) stake by 36% in Q2 2026, selling an estimated $1.62M and leaving 2,820 shares worth $3.38M. The position accounts for 0.45% of the portfolio, ranked #39.

TRB Wealth Management first reported a position in LLY in Q1 2026 and has held it in 2 quarters since. The position peaked at $4.05M in Q1 2026. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • TRB Wealth Management held 2,820 shares of Eli Lilly worth $3.38M as of Q2 2026.
  • TRB Wealth Management sold 1,585 Eli Lilly shares in Q2 2026, an estimated $1.62M.
  • Eli Lilly made up 0.45% of TRB Wealth Management's portfolio in Q2 2026, its #39 holding.
  • TRB Wealth Management first reported a position in Eli Lilly in Q1 2026 and has held it in 2 quarters since.
  • TRB Wealth Management's Eli Lilly position peaked at $4.05M in Q1 2026.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on TRB Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.